DCF — SOUTHEAST HEALTH MEDICAL CENTER
Enterprise Value: $-342.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-342.4M
Enterprise Value
$-115.9M
PV of Cash Flows
$-226.5M
PV of Terminal Value
$-364.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $439.9M | $-17.2M | -4.0% | $-35.8M | $-32.6M |
| Year 2 | $453.1M | $-13.2M | -3.0% | $-32.4M | $-26.7M |
| Year 3 | $466.7M | $-8.9M | -2.0% | $-28.7M | $-21.5M |
| Year 4 | $480.7M | $-6.8M | -1.0% | $-27.1M | $-18.5M |
| Year 5 | $495.2M | $-5.7M | -1.0% | $-26.7M | $-16.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-342.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$427.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04406525655915922
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5